These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 10983617
21. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up. Belda J, Giner J, Casan P, Sanchis J. Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162 [Abstract] [Full Text] [Related]
22. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Clin Exp Allergy; 1998 Feb; 28(2):233-40. PubMed ID: 9515598 [Abstract] [Full Text] [Related]
23. Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma. Visser MJ, Postma DS, Brand PL, Arends LR, Duiverman EJ, Kauffman HF. Clin Exp Allergy; 2002 Oct; 32(10):1497-503. PubMed ID: 12372131 [Abstract] [Full Text] [Related]
24. No impairment of peripheral deposition in novel asthmatics treated with an MDI corticosteroid with spacer. Saari SM, Vidgren MT, Turjanmaa VM, Koskinen MO, Nieminen MM. Respir Med; 2003 Feb; 97(2):152-8. PubMed ID: 12587966 [Abstract] [Full Text] [Related]
25. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma. Wever AM, Wever-Hess J, Hermans J. Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426 [Abstract] [Full Text] [Related]
26. Comparison of sputum and serum eosinophil cationic protein (ECP) levels in nonatopic asthma and chronic obstructive pulmonary disease. Gürsel G, Türktas H, Gökçora N, Tekin IO. J Asthma; 1997 May; 34(4):313-9. PubMed ID: 9250255 [Abstract] [Full Text] [Related]
27. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma. Bacci E, Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Dente FL, Giannini D, Vagaggini B, Ruocco L, Paggiaro PL. Eur Respir J; 2002 Jul; 20(1):66-72. PubMed ID: 12166584 [Abstract] [Full Text] [Related]
28. Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics. Dal Negro R, Micheletto C, Tognella S, Turco P, Rossetti A, Cantini L. Allergy; 2003 Oct; 58(10):1018-22. PubMed ID: 14510719 [Abstract] [Full Text] [Related]
29. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies. Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S. Int J Clin Pharmacol Res; 2003 Oct; 23(2-3):69-74. PubMed ID: 15025036 [Abstract] [Full Text] [Related]
30. Surplus value of eosinophil count and ECP to diagnose and monitor asthmatic patients. Pronk-Admiraal CJ, Haitjema T, Horikx P, Bartels PC. Neth J Med; 2001 Jan; 58(1):9-17. PubMed ID: 11137745 [Abstract] [Full Text] [Related]
31. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Allergy; 1994 Oct; 49(9):730-6. PubMed ID: 7695062 [Abstract] [Full Text] [Related]
32. Serum levels of eosinophil cationic protein and eosinophils in asthmatic children during a course of prednisolone therapy. Tang RB, Chen SJ. Pediatr Pulmonol; 2001 Feb; 31(2):121-5. PubMed ID: 11180687 [Abstract] [Full Text] [Related]
33. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. Grutters JC, Brinkman L, Aslander MM, van den Bosch JM, Koenderman L, Lammers JW. Eur Respir J; 1999 Oct; 14(4):915-22. PubMed ID: 10573242 [Abstract] [Full Text] [Related]
34. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms. Zimmerman B, Enander I, Zimmerman R, Ahlstedt S. Clin Exp Allergy; 1994 Feb; 24(2):149-55. PubMed ID: 8187030 [Abstract] [Full Text] [Related]
35. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation]. Ohbayashi H. Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673 [Abstract] [Full Text] [Related]
36. Evaluation of serum eosinophil cationic protein as a predictive marker for asthma exacerbation in patients with persistent disease. Sorkness C, McGill K, Busse WW. Clin Exp Allergy; 2002 Sep; 32(9):1355-9. PubMed ID: 12220475 [Abstract] [Full Text] [Related]
37. Is serum ECP level helpful in determining discontinuation of inhaled corticosteroid therapy in asthmatic children? Bahceciler NN, Basdemir D, Nursoy AM, Nuhoğlu Y, Barlan IB, Basaran MM. Allergol Immunopathol (Madr); 2000 Sep; 28(5):278-82. PubMed ID: 11270089 [Abstract] [Full Text] [Related]
38. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. Lönnkvist K, Hellman C, Lundahl J, Halldén G, Hedlin G. J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347 [Abstract] [Full Text] [Related]
39. Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma. Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M. Arzneimittelforschung; 1999 Jan; 49(1):35-7. PubMed ID: 10028377 [Abstract] [Full Text] [Related]